Showing results (71-80 of 1,520) with videos related to
Sort By:
Pageof 152
CPT: Pharmacometrics & Systems Pharmacology|July 28, 2022
Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluationHanna Kunina, Alex Al-Mashat, Jenny Y Chien, et al.CPT: Pharmacometrics & Systems Pharmacology|October 5, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib studyImke H Bartelink, Pierre M Bet, Nicolas Widmer, et al.CPT: Pharmacometrics & Systems Pharmacology|July 12, 2022
Tumor growth inhibition modeling to support the starting dose for dacomitinibLuke K Fostvedt, Dana J Nickens, Weiwei Tan, et al.CPT: Pharmacometrics & Systems Pharmacology|May 2, 2022
Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesityJacqueline G Gerhart, Fernando O Carreño, Jennifer L Ford, et al.CPT: Pharmacometrics & Systems Pharmacology|May 16, 2018
Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii PneumoniaJohn K Diep, Thomas A Russo, Gauri G RaoCPT: Pharmacometrics & Systems Pharmacology|December 5, 2023
Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model-informed drug development case studyLindsay E Clegg, Lulu Chu, Mats Nagard, et al.CPT: Pharmacometrics & Systems Pharmacology|December 2, 2023
Physiologically-based pharmacokinetic model of sparsentan to evaluate drug-drug interaction potentialNikunjkumar K Patel, Kuan-Fu Chen, Shang-Chiung Chen, et al.CPT: Pharmacometrics & Systems Pharmacology|December 3, 2023
Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL-6 levels following administration of the T-cell bispecific engager glofitamabNassim Djebli, Neil Parrott, Felix Jaminion, et al.CPT: Pharmacometrics & Systems Pharmacology|November 29, 2023
Bayesian estimation in NONMEMCurtis K Johnston, Timothy Waterhouse, Matthew Wiens, et al.CPT: Pharmacometrics & Systems Pharmacology|November 2, 2023
Application of the model-informed drug development paradigm to datopotamab deruxtecan dose selection for late-stage developmentYasong Lu, Shuang Liang, Ying Hong, et al.Pageof 152